Tulane University Awarded $12 Million to Create Lassa Fever Vaccine and Treatment
Tulane UniversityThe National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.